Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-01-15

AUTHORS

Chase S. Correia, Melissa R. Briones, Rong Guo, Rochella A. Ostrowski

ABSTRACT

This paper is to examine the relationship between anti-cyclic citrullinated peptide (anti-CCP) antibody titers and the development of interstitial lung disease (ILD) in patients with and without rheumatoid arthritis (RA). A retrospective investigation was conducted on all adult patients tested for anti-CCP between January 1, 2007, and December 31, 2012, in a university healthcare system. Patients with specified exposures or conditions known to cause ILD were excluded. The prevalence of ILD was compared between those with and without a positive CCP. The study population was then divided into four titer groups based on anti-CCP titers: negative, low titer, moderate titer, high titer. Fisher’s exact tests compared the prevalence of ILD among the anti-CCP titer groups. Multivariate logistic regression examined the association between anti-CCP and ILD while controlling for confounders. These analyses were repeated in two subgroups: a “confirmed RA” subgroup and an “unconfirmed RA” subgroup. Two thousand and thirty patients met inclusion criteria and 453 of those had confirmed RA. Progressively higher anti-CCP titer groups developed an increasingly higher prevalence of ILD (p < 0.01). When adjusting for age, tobacco, and a diagnosis of RA, higher anti-CCP titer groups continued to correlate with an increased prevalence of ILD (OR 1.47, 95% CI 1.10–1.96, p < 0.001). This study is the first to show that progressively higher anti-CCP titers correlate with increasing prevalence of ILD, even when adjusting for confounders. More... »

PAGES

1201-1206

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0

DOI

http://dx.doi.org/10.1007/s10067-018-04421-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111431338

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30645754


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Citrullinated Protein Antibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Diseases, Interstitial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Rheumatology, Northwestern Memorial Hospital, 675 North Saint Clair Street, 14th Floor Suite 100, 60611, Chicago, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.416565.5", 
          "name": [
            "Division of Rheumatology, Northwestern Memorial Hospital, 675 North Saint Clair Street, 14th Floor Suite 100, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Correia", 
        "givenName": "Chase S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.411451.4", 
          "name": [
            "Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Briones", 
        "givenName": "Melissa R.", 
        "id": "sg:person.010710573113.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010710573113.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine Statistics Core, University of California, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Department of Medicine Statistics Core, University of California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guo", 
        "givenName": "Rong", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.411451.4", 
          "name": [
            "Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ostrowski", 
        "givenName": "Rochella A.", 
        "id": "sg:person.01070402624.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070402624.85"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12026-013-8395-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004035819", 
          "https://doi.org/10.1007/s12026-013-8395-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-28753-4_201937", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002203233", 
          "https://doi.org/10.1007/978-3-642-28753-4_201937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10067-007-0800-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025478929", 
          "https://doi.org/10.1007/s10067-007-0800-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01-15", 
    "datePublishedReg": "2019-01-15", 
    "description": "This paper is to examine the relationship between anti-cyclic citrullinated peptide (anti-CCP) antibody titers and the development of interstitial lung disease (ILD) in patients with and without rheumatoid arthritis (RA). A retrospective investigation was conducted on all adult patients tested for anti-CCP between January 1, 2007, and December 31, 2012, in a university healthcare system. Patients with specified exposures or conditions known to cause ILD were excluded. The prevalence of ILD was compared between those with and without a positive CCP. The study population was then divided into four titer groups based on anti-CCP titers: negative, low titer, moderate titer, high titer. Fisher\u2019s exact tests compared the prevalence of ILD among the anti-CCP titer groups. Multivariate logistic regression examined the association between anti-CCP and ILD while controlling for confounders. These analyses were repeated in two subgroups: a \u201cconfirmed RA\u201d subgroup and an \u201cunconfirmed RA\u201d subgroup. Two thousand and thirty patients met inclusion criteria and 453 of those had confirmed RA. Progressively higher anti-CCP titer groups developed an increasingly higher prevalence of ILD (p\u2009<\u20090.01). When adjusting for age, tobacco, and a diagnosis of RA, higher anti-CCP titer groups continued to correlate with an increased prevalence of ILD (OR 1.47, 95% CI 1.10\u20131.96, p\u2009<\u20090.001). This study is the first to show that progressively higher anti-CCP titers correlate with increasing prevalence of ILD, even when adjusting for confounders.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10067-018-04421-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7072407", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1093299", 
        "issn": [
          "0770-3198", 
          "1434-9949"
        ], 
        "name": "Clinical Rheumatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "38"
      }
    ], 
    "keywords": [
      "prevalence of ILD", 
      "interstitial lung disease", 
      "peptide antibody titer", 
      "rheumatoid arthritis", 
      "anti-CCP titers", 
      "titer group", 
      "lung disease", 
      "antibody titers", 
      "exact test", 
      "diagnosis of RA", 
      "multivariate logistic regression", 
      "university healthcare system", 
      "Fisher's exact test", 
      "adult patients", 
      "Anti-CCP", 
      "moderate titers", 
      "inclusion criteria", 
      "high prevalence", 
      "study population", 
      "retrospective investigation", 
      "patients", 
      "low titers", 
      "high titers", 
      "logistic regression", 
      "prevalence", 
      "titers", 
      "healthcare system", 
      "confounders", 
      "subgroups", 
      "disease", 
      "group", 
      "arthritis", 
      "diagnosis", 
      "age", 
      "risk", 
      "CCP", 
      "exposure", 
      "association", 
      "regression", 
      "tobacco", 
      "population", 
      "criteria", 
      "study", 
      "test", 
      "development", 
      "relationship", 
      "investigation", 
      "analysis", 
      "conditions", 
      "system", 
      "paper", 
      "positive CCP", 
      "CCP titer groups", 
      "unconfirmed RA", 
      "higher anti-CCP titer groups", 
      "anti-CCP titer groups", 
      "higher anti-CCP titers"
    ], 
    "name": "Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease", 
    "pagination": "1201-1206", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111431338"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10067-018-04421-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30645754"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10067-018-04421-0", 
      "https://app.dimensions.ai/details/publication/pub.1111431338"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_820.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10067-018-04421-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      22 PREDICATES      95 URIs      84 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10067-018-04421-0 schema:about N131b56530d8842499f1d5cd9cbb0aa3e
2 N2cfd81d813254ba3a40d314251eaa41c
3 N75e90358b082423a8f8a9417863bbaf5
4 N84d5f358453a4315b552e87daef5adb4
5 Na05a864b2fe24ecba2345d22bfe79829
6 Nc8765e0e40d748cc875a7429d7ed3a30
7 Ncf6117b665204150bf2ec246d3584e9c
8 Ne4f360c42db94f9aae321ab14b9dee98
9 Nffdb316d83a54d8a8af98add7b63db44
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author Nce72e666c0344890b8a4f72f1c1d0ea3
13 schema:citation sg:pub.10.1007/978-3-642-28753-4_201937
14 sg:pub.10.1007/s10067-007-0800-1
15 sg:pub.10.1007/s12026-013-8395-x
16 schema:datePublished 2019-01-15
17 schema:datePublishedReg 2019-01-15
18 schema:description This paper is to examine the relationship between anti-cyclic citrullinated peptide (anti-CCP) antibody titers and the development of interstitial lung disease (ILD) in patients with and without rheumatoid arthritis (RA). A retrospective investigation was conducted on all adult patients tested for anti-CCP between January 1, 2007, and December 31, 2012, in a university healthcare system. Patients with specified exposures or conditions known to cause ILD were excluded. The prevalence of ILD was compared between those with and without a positive CCP. The study population was then divided into four titer groups based on anti-CCP titers: negative, low titer, moderate titer, high titer. Fisher’s exact tests compared the prevalence of ILD among the anti-CCP titer groups. Multivariate logistic regression examined the association between anti-CCP and ILD while controlling for confounders. These analyses were repeated in two subgroups: a “confirmed RA” subgroup and an “unconfirmed RA” subgroup. Two thousand and thirty patients met inclusion criteria and 453 of those had confirmed RA. Progressively higher anti-CCP titer groups developed an increasingly higher prevalence of ILD (p < 0.01). When adjusting for age, tobacco, and a diagnosis of RA, higher anti-CCP titer groups continued to correlate with an increased prevalence of ILD (OR 1.47, 95% CI 1.10–1.96, p < 0.001). This study is the first to show that progressively higher anti-CCP titers correlate with increasing prevalence of ILD, even when adjusting for confounders.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree true
22 schema:isPartOf N09f93607af5f4ff6b65679e56561d8ff
23 N335baeb05cce470384fba09d45d6a5f3
24 sg:journal.1093299
25 schema:keywords Anti-CCP
26 CCP
27 CCP titer groups
28 Fisher's exact test
29 adult patients
30 age
31 analysis
32 anti-CCP titer groups
33 anti-CCP titers
34 antibody titers
35 arthritis
36 association
37 conditions
38 confounders
39 criteria
40 development
41 diagnosis
42 diagnosis of RA
43 disease
44 exact test
45 exposure
46 group
47 healthcare system
48 high prevalence
49 high titers
50 higher anti-CCP titer groups
51 higher anti-CCP titers
52 inclusion criteria
53 interstitial lung disease
54 investigation
55 logistic regression
56 low titers
57 lung disease
58 moderate titers
59 multivariate logistic regression
60 paper
61 patients
62 peptide antibody titer
63 population
64 positive CCP
65 prevalence
66 prevalence of ILD
67 regression
68 relationship
69 retrospective investigation
70 rheumatoid arthritis
71 risk
72 study
73 study population
74 subgroups
75 system
76 test
77 titer group
78 titers
79 tobacco
80 unconfirmed RA
81 university healthcare system
82 schema:name Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease
83 schema:pagination 1201-1206
84 schema:productId N0b2a8e7e91034dc0b3936612edfb785f
85 N21abd9f3265744c2920fe0af7c1214ed
86 N9c821219209b464eba28e7b0ce8a91af
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111431338
88 https://doi.org/10.1007/s10067-018-04421-0
89 schema:sdDatePublished 2021-12-01T19:45
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher Nf663bbe0ec6947c28676b80e4295b564
92 schema:url https://doi.org/10.1007/s10067-018-04421-0
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N09f93607af5f4ff6b65679e56561d8ff schema:volumeNumber 38
97 rdf:type schema:PublicationVolume
98 N0b2a8e7e91034dc0b3936612edfb785f schema:name pubmed_id
99 schema:value 30645754
100 rdf:type schema:PropertyValue
101 N131b56530d8842499f1d5cd9cbb0aa3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Anti-Citrullinated Protein Antibodies
103 rdf:type schema:DefinedTerm
104 N21abd9f3265744c2920fe0af7c1214ed schema:name dimensions_id
105 schema:value pub.1111431338
106 rdf:type schema:PropertyValue
107 N25da50579b8143d097a3a924bae7d842 rdf:first sg:person.01070402624.85
108 rdf:rest rdf:nil
109 N2cfd81d813254ba3a40d314251eaa41c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Female
111 rdf:type schema:DefinedTerm
112 N335baeb05cce470384fba09d45d6a5f3 schema:issueNumber 4
113 rdf:type schema:PublicationIssue
114 N5c5ba9b6d66b42368adf4872a2e6c62e schema:affiliation grid-institutes:grid.19006.3e
115 schema:familyName Guo
116 schema:givenName Rong
117 rdf:type schema:Person
118 N65e76821987142249efff1007518d192 rdf:first sg:person.010710573113.64
119 rdf:rest N89485da324764a6b96305cad97c5f880
120 N75e90358b082423a8f8a9417863bbaf5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Male
122 rdf:type schema:DefinedTerm
123 N7d388ee87d204dc0aaa87b46de95ba85 schema:affiliation grid-institutes:grid.416565.5
124 schema:familyName Correia
125 schema:givenName Chase S.
126 rdf:type schema:Person
127 N84d5f358453a4315b552e87daef5adb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Biomarkers
129 rdf:type schema:DefinedTerm
130 N89485da324764a6b96305cad97c5f880 rdf:first N5c5ba9b6d66b42368adf4872a2e6c62e
131 rdf:rest N25da50579b8143d097a3a924bae7d842
132 N9c821219209b464eba28e7b0ce8a91af schema:name doi
133 schema:value 10.1007/s10067-018-04421-0
134 rdf:type schema:PropertyValue
135 Na05a864b2fe24ecba2345d22bfe79829 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Lung Diseases, Interstitial
137 rdf:type schema:DefinedTerm
138 Nc8765e0e40d748cc875a7429d7ed3a30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Risk Factors
140 rdf:type schema:DefinedTerm
141 Nce72e666c0344890b8a4f72f1c1d0ea3 rdf:first N7d388ee87d204dc0aaa87b46de95ba85
142 rdf:rest N65e76821987142249efff1007518d192
143 Ncf6117b665204150bf2ec246d3584e9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Humans
145 rdf:type schema:DefinedTerm
146 Ne4f360c42db94f9aae321ab14b9dee98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Retrospective Studies
148 rdf:type schema:DefinedTerm
149 Nf663bbe0ec6947c28676b80e4295b564 schema:name Springer Nature - SN SciGraph project
150 rdf:type schema:Organization
151 Nffdb316d83a54d8a8af98add7b63db44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Middle Aged
153 rdf:type schema:DefinedTerm
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
158 schema:name Clinical Sciences
159 rdf:type schema:DefinedTerm
160 sg:grant.7072407 http://pending.schema.org/fundedItem sg:pub.10.1007/s10067-018-04421-0
161 rdf:type schema:MonetaryGrant
162 sg:journal.1093299 schema:issn 0770-3198
163 1434-9949
164 schema:name Clinical Rheumatology
165 schema:publisher Springer Nature
166 rdf:type schema:Periodical
167 sg:person.01070402624.85 schema:affiliation grid-institutes:grid.411451.4
168 schema:familyName Ostrowski
169 schema:givenName Rochella A.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070402624.85
171 rdf:type schema:Person
172 sg:person.010710573113.64 schema:affiliation grid-institutes:grid.411451.4
173 schema:familyName Briones
174 schema:givenName Melissa R.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010710573113.64
176 rdf:type schema:Person
177 sg:pub.10.1007/978-3-642-28753-4_201937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002203233
178 https://doi.org/10.1007/978-3-642-28753-4_201937
179 rdf:type schema:CreativeWork
180 sg:pub.10.1007/s10067-007-0800-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025478929
181 https://doi.org/10.1007/s10067-007-0800-1
182 rdf:type schema:CreativeWork
183 sg:pub.10.1007/s12026-013-8395-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004035819
184 https://doi.org/10.1007/s12026-013-8395-x
185 rdf:type schema:CreativeWork
186 grid-institutes:grid.19006.3e schema:alternateName Department of Medicine Statistics Core, University of California, Los Angeles, CA, USA
187 schema:name Department of Medicine Statistics Core, University of California, Los Angeles, CA, USA
188 rdf:type schema:Organization
189 grid-institutes:grid.411451.4 schema:alternateName Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA
190 schema:name Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA
191 rdf:type schema:Organization
192 grid-institutes:grid.416565.5 schema:alternateName Division of Rheumatology, Northwestern Memorial Hospital, 675 North Saint Clair Street, 14th Floor Suite 100, 60611, Chicago, IL, USA
193 schema:name Division of Rheumatology, Northwestern Memorial Hospital, 675 North Saint Clair Street, 14th Floor Suite 100, 60611, Chicago, IL, USA
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...